Jodi Devlin - May 19, 2025 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Role
Chief of Clinical Operations
Signature
/s/ Mary Szela, Attorney-in-Fact
Stock symbol
TLSI
Transactions as of
May 19, 2025
Transactions value $
$100,321
Form type
4
Date filed
5/21/2025, 05:31 PM
Previous filing
Feb 19, 2025
Next filing
Nov 25, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Devlin Jodi Chief of Clinical Operations 6272 W. 91ST AVENUE, WESTMINSTER /s/ Mary Szela, Attorney-in-Fact 2025-05-21 0001992151

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TLSI Common Stock Award $125K +24.1K +72.25% $5.18 57.5K May 19, 2025 Direct F1
transaction TLSI Common Stock Sale -$24.7K -4.76K -8.28% $5.18 52.8K May 19, 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The granted RSUs vest immediately.
F2 The sale of the shares was to cover the tax liability associated with the granted RSUs.